Geneva Advisors’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
– Sell
-5,140
Closed -$349K – 688
2015
Q2
$349K Buy
5,140
+860
+20% +$60.8K 0.01% 495
2015
Q1
$254K Sell
4,280
-150
-3% -$8.55K ﹤0.01% 553
2014
Q4
$250K Sell
4,430
-2,551
-37% -$137K ﹤0.01% 556
2014
Q3
$318K Hold
6,981
– – 0.01% 503
2014
Q2
$360K Sell
6,981
-1,500
-18% -$73.7K 0.01% 485
2014
Q1
$414K Buy
8,481
+1,700
+25% +$82.5K 0.01% 427
2013
Q4
$294K Sell
6,781
-1,999
-23% -$82.2K 0.01% 403
2013
Q3
$335K Buy
8,780
+500
+6% +$17.6K 0.01% 381
2013
Q2
$257K Buy
+8,280
New +$247K 0.01% 359

Other funds holding VTRS

Geneva Advisors's VTRS Position: Q3 2015 in Review

Geneva Advisors sold out of Viatris (VTRS) in Q3 2015, closing a stake of 5,140 shares — an estimated $349K sold.

Geneva Advisors first reported a position in VTRS in Q2 2013 and held it in 9 quarters. The position peaked at $414K in Q1 2014. 612 funds tracked by Wall St. Rank hold VTRS as of Q3 2015.

  • Geneva Advisors reported no remaining Viatris position as of Q3 2015 after selling out during the quarter.
  • Geneva Advisors sold 5,140 Viatris shares in Q3 2015, an estimated $349K.
  • Geneva Advisors first reported a position in Viatris in Q2 2013 and held it in 9 quarters.
  • Geneva Advisors's Viatris position peaked at $414K in Q1 2014.
  • 612 funds tracked by Wall St. Rank held Viatris as of Q3 2015.

Based on Geneva Advisors's 13F filing for Q3 2015, filed 3 Nov 2015.